1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Hrabal, R.
Komives, E.A.
Ni, F.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
US
Protein Sci.
PRCIEI
0795
0961-8368
5
195
203
8745396
Structural resiliency of an EGF-like subdomain bound to its target protein, thrombin.
1996
10.2210/pdb1fge/pdb
pdb_00001fge
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
NON-NATIVE DISULFIDE BOND BETWEEN THE FOURTH CYSTEINE (CYS 407) AND THE SIXTH CYSTEINE (CYS 421)
2218.372
THROMBOMODULIN
C-TERMINAL SUBDOMAIN, RESIDUES 407 - 426, OF 5TH EPIDERMAL GROWTH FACTOR (EGF)
C409A
1
man
polymer
no
no
CEAPEGYILDDGFICTDIDE
CEAPEGYILDDGFICTDIDE
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
9606
Homo sapiens
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1996-06-20
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_struct_ref_seq_dif.details
Y
BNL
1995-11-28
REL
REL
14
BRUNGER
refinement
X-PLOR
3.1
CYS
407
n
1
CYS
407
A
GLU
408
n
2
GLU
408
A
ALA
409
n
3
ALA
409
A
PRO
410
n
4
PRO
410
A
GLU
411
n
5
GLU
411
A
GLY
412
n
6
GLY
412
A
TYR
413
n
7
TYR
413
A
ILE
414
n
8
ILE
414
A
LEU
415
n
9
LEU
415
A
ASP
416
n
10
ASP
416
A
ASP
417
n
11
ASP
417
A
GLY
418
n
12
GLY
418
A
PHE
419
n
13
PHE
419
A
ILE
420
n
14
ILE
420
A
CYS
421
n
15
CYS
421
A
THR
422
n
16
THR
422
A
ASP
423
n
17
ASP
423
A
ILE
424
n
18
ILE
424
A
ASP
425
n
19
ASP
425
A
GLU
426
n
20
GLU
426
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
ILE
414
-170.10
112.07
1
A
PHE
419
77.11
147.15
1
A
ILE
420
-138.85
-63.40
1
A
CYS
421
177.68
98.90
1
A
THR
422
69.84
122.76
1
A
ASP
423
-148.12
-53.48
1
A
ASP
425
-112.30
72.69
2
A
ILE
414
-169.71
105.15
2
A
PHE
419
75.14
148.83
2
A
ILE
420
-143.86
-59.89
2
A
CYS
421
178.13
96.12
2
A
THR
422
70.21
122.66
2
A
ASP
423
-145.75
-60.68
2
A
ASP
425
-104.64
62.12
3
A
GLU
408
66.60
148.27
3
A
ILE
414
-171.10
104.83
3
A
PHE
419
75.03
147.25
3
A
ILE
420
-142.18
-63.82
3
A
CYS
421
-179.49
105.94
3
A
THR
422
67.16
116.53
3
A
ASP
423
-149.76
-60.91
3
A
ASP
425
-104.65
65.63
4
A
GLU
408
66.41
150.58
4
A
ILE
414
-171.68
105.23
4
A
PHE
419
73.05
147.64
4
A
ILE
420
-143.10
-63.51
4
A
CYS
421
-178.42
101.19
4
A
THR
422
70.02
118.61
4
A
ASP
423
-148.28
-54.79
4
A
ASP
425
-106.70
71.28
5
A
ILE
414
-172.38
102.59
5
A
PHE
419
73.72
147.62
5
A
ILE
420
-143.77
-61.86
5
A
CYS
421
179.50
110.88
5
A
THR
422
64.49
103.62
5
A
ASP
423
-142.25
-37.13
6
A
GLU
408
66.27
150.65
6
A
ILE
414
-170.60
103.26
6
A
PHE
419
71.82
147.92
6
A
ILE
420
-143.13
-62.59
6
A
CYS
421
178.48
112.68
6
A
THR
422
66.24
103.93
6
A
ASP
423
-143.05
-39.20
7
A
GLU
408
65.32
154.96
7
A
ILE
414
-172.35
105.78
7
A
PHE
419
70.88
148.11
7
A
ILE
420
-143.78
-63.47
7
A
CYS
421
-177.84
101.27
7
A
THR
422
70.85
118.48
7
A
ASP
423
-147.84
-54.12
7
A
ASP
425
-106.83
71.16
8
A
ILE
414
-165.88
112.62
8
A
PHE
419
77.68
146.57
8
A
ILE
420
-140.92
-57.40
8
A
CYS
421
-171.14
-132.61
8
A
ASP
425
-117.96
75.50
9
A
GLU
408
65.93
153.63
9
A
ILE
414
-161.90
111.78
9
A
PHE
419
73.56
146.28
9
A
ILE
420
-143.81
-59.30
9
A
CYS
421
-166.98
-129.92
9
A
ASP
423
-145.61
-55.02
9
A
ASP
425
-115.23
71.70
10
A
ILE
414
-160.65
111.06
10
A
PHE
419
71.20
148.05
10
A
ILE
420
-143.29
-56.97
10
A
CYS
421
-173.72
-125.14
10
A
ASP
423
-144.22
-54.67
10
A
ASP
425
-114.60
73.49
11
A
PRO
410
-74.87
-168.24
11
A
ILE
414
-171.40
104.19
11
A
PHE
419
75.01
148.35
11
A
ILE
420
-143.77
-60.90
11
A
CYS
421
178.90
97.37
11
A
THR
422
70.29
122.46
11
A
ASP
423
-148.68
-52.22
11
A
ASP
425
-112.56
73.85
12
A
GLU
408
66.15
151.18
12
A
ILE
414
-160.01
111.18
12
A
PHE
419
70.97
146.33
12
A
ILE
420
-143.42
-59.29
12
A
CYS
421
-168.18
-131.07
12
A
ASP
423
-139.34
-60.54
12
A
ASP
425
-106.16
58.59
13
A
ILE
414
-170.21
102.38
13
A
PHE
419
74.82
147.83
13
A
ILE
420
-144.01
-60.53
13
A
CYS
421
177.26
107.78
13
A
THR
422
65.16
107.10
13
A
ASP
423
-144.19
-39.49
13
A
ASP
425
-100.66
64.37
14
A
GLU
408
67.98
142.12
14
A
ILE
414
-173.22
107.31
14
A
PHE
419
72.67
148.84
14
A
ILE
420
-142.85
-62.72
14
A
CYS
421
-179.40
97.36
14
A
THR
422
70.73
121.65
14
A
ASP
423
-145.99
-55.89
14
A
ASP
425
-104.03
69.13
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
phasing
X-PLOR
3.1
EPIDERMAL GROWTH FACTOR (EGF) SUBDOMAIN OF HUMAN THROMBOMODULIN (NMR, 14 STRUCTURES)
1
Y
N
disulf
2.024
A
CYS
407
A
SG
CYS
1
1_555
A
CYS
421
A
SG
CYS
15
1_555
BLOOD COAGULATION INHIBITOR
BLOOD COAGULATION INHIBITOR, THROMBOMODULIN, EGF
TRBM_HUMAN
UNP
1
1
P07204
MLGVLVLGALALAGLGFPAPAEPQPGGSQCVEHDCFALYPGPATFLNASQICDGLRGHLMTVRSSVAADVISLLLNGDGG
VGRRRLWIGLQLPPGCGDPKRLGPLRGFQWVTGDNNTSYSRWARLDLNGAPLCGPLCVAVSAAEATVPSEPIWEEQQCEV
KADGFLCEFHFPATCRPLAVEPGAAAAAVSITYGTPFAARGADFQALPVGSSAAVAPLGLQLMCTAPPGAVQGHWAREAP
GAWDCSVENGGCEHACNAIPGAPRCQCPAGAALQADGRSCTASATQSCNDLCEHFCVPNPDQPGSYSCMCETGYRLAADQ
HRCEDVDDCILEPSPCPQRCVNTQGGFECHCYPNYDLVDGECVEPVDPCFRANCEYQCQPLNQTSYLCVCAEGFAPIPHE
PHRCQMFCNQTACPADCDPNTQASCECPEGYILDDGFICTDIDECENGGFCSGVCHNLPGTFECICGPDSALARHIGTDC
DSGKVDGGDSGSGEPPPSPTPGSTLTPPAVGLVHSGLLIGISIASLCLVVALLALLCHLRKKQGAARAKMEYKCAAPSKE
VVLQHVRTERTPQRL
425
444
1FGE
407
426
P07204
A
1
1
20
1
CYS
conflict
ALA
409
1FGE
A
P07204
UNP
427
3
1
P 1